SOST and osteoporosis: Multiple studies have reported lower sclerostin levels in patients with osteoporosis or osteopenia compared to individuals with normal bone mass (28, 29), a finding also observed in postmenopausal women (30), which may be attributed to an age-related decline in osteocyte number (28).